Chronic Obstructive Pulmonary Disease Diagnosis and Management in Older Adults

被引:49
作者
Gooneratne, Nalaka S. [1 ,2 ]
Patel, Nirav P. [2 ,3 ]
Corcoran, Amy [1 ]
机构
[1] Univ Penn, Sch Med, Div Geriatr Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA
[3] Reading Hosp Med Ctr, Pulm Crit Care & Sleep Med, Reading, PA USA
关键词
COPD; older adult; diagnosis; management; bronchodilators; AIR-FLOW OBSTRUCTION; CHRONIC LUNG-DISEASE; OF-LIFE; INHALED CORTICOSTEROIDS; FLUTICASONE PROPIONATE; ELDERLY PATIENTS; COPD; RISK; TIOTROPIUM; THERAPY;
D O I
10.1111/j.1532-5415.2010.02875.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Chronic obstructive pulmonary disease (COPD) in older adults is a complex disorder with several unique age-related aspects. Underlying changes in pulmonary lung function and poor sensitivity to bronchoconstriction and hypoxia with advancing age can place older adults at greater risk of mortality or other complications from COPD. The establishment of the Global Initiative for Obstructive Lung Disease criteria, which can be effectively applied to older adults, has more rigorously defined the diagnosis and management of COPD. An important component of this approach is the use of spirometry for disease staging, a procedure that can be performed in most older adults. The management of COPD includes smoking cessation, influenza and pneumococcal vaccinations, and the use of short- and long-acting bronchodilators. Unlike with asthma, corticosteroid inhalers represent a third-line option for COPD. Combination therapy is frequently required. When using various inhaler designs, it is important to note that older adults, especially those with more-severe disease, may have inadequate inspiratory force for some dry-powder inhalers, although many older adults find the dry-powder inhalers easier to use than metered-dose inhalers. Other important treatment options include pulmonary rehabilitation, oxygen therapy, noninvasive positive airway pressure, and depression and osteopenia screening. Clinicians caring for older adults with an acute COPD exacerbation should also guard against prognostic pessimism. Although COPD is associated with significant disability, there is a growing range of treatment options to assist patients. J Am Geriatr Soc 58: 1153-1162, 2010.
引用
收藏
页码:1153 / 1162
页数:10
相关论文
共 60 条
[1]   Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease - A randomized trial [J].
Aaron, Shawn D. ;
Vandemheen, Katherine L. ;
Fergusson, Dean ;
Maltais, Francois ;
Bourbeau, Jean ;
Goldstein, Roger ;
Balter, Meyer ;
O'Donnell, Denis ;
McIvor, Andrew ;
Sharma, Sat ;
Bishop, Graham ;
Anthony, John ;
Cowie, Robert ;
Field, Stephen ;
Hirsch, Andrew ;
Hernandez, Paul ;
Rivington, Robert ;
Road, Jeremy ;
Hoffstein, Victor ;
Hodder, Richard ;
Marciniuk, Darcy ;
McCormack, David ;
Fox, George ;
Cox, Gerard ;
Prins, Henry B. ;
Ford, Gordon ;
Bleskie, Dominique ;
Doucette, Steve ;
Mayers, Irvin ;
Chapman, Kenneth ;
Zamel, Noe ;
FitzGerald, Mark .
ANNALS OF INTERNAL MEDICINE, 2007, 146 (08) :545-U15
[2]   COPD as a Systemic Disease [J].
Agusti, Alvar ;
Soriano, Joan B. .
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2008, 5 (02) :133-138
[3]   Inability to draw intersecting pentagons as a predictor of unsatisfactory spirometry technique in elderly hospital inpatients [J].
Allen, SC ;
Yeung, P .
AGE AND AGEING, 2006, 35 (03) :304-306
[4]  
Allen SC, 2000, J HONG KONG GERIATR, V10, P75
[5]   Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease [J].
Appleton, S. ;
Jones, T. ;
Poole, P. ;
Pilotto, L. ;
Adams, R. ;
Lasserson, T. J. ;
Smith, B. ;
Muhammad, J. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (02)
[6]   Risk of mortality and heart failure exacerbations associated with inhaled β-adrenoceptor agonists among patients with known left ventricular systolic dysfunction [J].
Au, DH ;
Udris, EM ;
Fan, VS ;
Curtis, JR ;
McDonell, MB ;
Fihn, SD .
CHEST, 2003, 123 (06) :1964-1969
[7]  
Bridevaux PO, 2008, THORAX, V63, P768, DOI 10.1136/thx.2007.093724
[8]   Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial [J].
Burge, PS ;
Calverley, PMA ;
Jones, PW ;
Spencer, S ;
Anderson, JA ;
Maslen, TK .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7245) :1297-1303
[9]   Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease [J].
Calverley, Peter M. A. ;
Anderson, Julie A. ;
Celli, Bartolome ;
Ferguson, Gary T. ;
Jenkins, Christine ;
Jones, Paul W. ;
Yates, Julie C. ;
Vestbo, Jorgen ;
Calverley, P. M. A. ;
Anderson, J. A. ;
Celli, B. ;
Ferguson, G. T. ;
Jenkins, C. ;
Jones, P. W. ;
Knobil, K. ;
Yates, J. C. ;
Vestbo, J. ;
Cherniack, R. ;
Similowski, T. ;
Cleland, J. ;
Whitehead, A. ;
Wise, R. ;
McGarvey, L. ;
John, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :775-789
[10]   Bronchodilator reversibility testing in chronic obstructive pulmonary disease [J].
Calverley, PMA ;
Burge, PS ;
Spencer, S ;
Anderson, JA ;
Jones, PW .
THORAX, 2003, 58 (08) :659-664